UnitedHealth Group’s (UNH) “Overweight” Rating Reaffirmed at Cantor Fitzgerald

Cantor Fitzgerald reaffirmed their overweight rating on shares of UnitedHealth Group (NYSE:UNH) in a research report released on Tuesday,Benzinga reports. They currently have a $440.00 target price on the healthcare conglomerate’s stock.

A number of other equities research analysts have also recently issued reports on UNH. Mizuho cut their target price on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a research note on Friday, May 16th. Erste Group Bank cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, April 30th. Barclays reiterated an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. KeyCorp cut their target price on UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 30th. Finally, JPMorgan Chase & Co. cut their price objective on shares of UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating on the stock in a research note on Wednesday, August 6th. Fifteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $353.00.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $302.66 on Tuesday. The company has a market cap of $274.11 billion, a PE ratio of 13.11, a P/E/G ratio of 1.96 and a beta of 0.43. The company has a fifty day moving average price of $288.01 and a two-hundred day moving average price of $383.24. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group has a 12 month low of $234.60 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts expect that UnitedHealth Group will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be given a $2.21 dividend. The ex-dividend date is Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.9%. UnitedHealth Group’s payout ratio is 38.30%.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the business’s stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer directly owned 10,398 shares in the company, valued at approximately $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.28% of the company’s stock.

Institutional Investors Weigh In On UnitedHealth Group

Hedge funds and other institutional investors have recently bought and sold shares of the business. Citizens National Bank Trust Department increased its stake in UnitedHealth Group by 1.0% in the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock worth $9,368,000 after purchasing an additional 170 shares in the last quarter. Fort Washington Investment Advisors Inc. OH grew its stake in UnitedHealth Group by 0.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock valued at $277,641,000 after acquiring an additional 1,465 shares in the last quarter. Caitlin John LLC grew its stake in UnitedHealth Group by 14.8% during the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock valued at $451,000 after acquiring an additional 111 shares in the last quarter. Sherbrooke Park Advisers LLC purchased a new position in UnitedHealth Group during the 4th quarter valued at about $515,000. Finally, Full Sail Capital LLC grew its stake in UnitedHealth Group by 2.1% during the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock valued at $815,000 after acquiring an additional 33 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.